TIGAR cooperated with glycolysis to inhibit the apoptosis of leukemia cells and associated with poor prognosis in patients with cytogenetically normal acute myeloid leukemia.

J Hematol Oncol · 2016 · PMC5123356 · PMID 27884166

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The 54 patients from TIGAR high group also showed a trend towards a higher relapse rate than those from TIGAR low group (29.1 vs. 18.2%), although statistical significance was not reached.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.